Ever-Link Fertility Centre (GenPrime Everlink)

Ever-Link Fertility Centre (GenPrime Everlink) — Shah Alam Assisted Reproduction Clinic

About Ever-Link Fertility Centre

Ever-Link Fertility Centre, operating as GenPrime Everlink Fertility Centre, is an IVF specialty clinic in UOA Business Park, Shah Alam, Selangor, running since 2018 under registered company Saixu M Sdn Bhd. It belongs to the GenPrime global clinic network within the Rhea Fertility international reproductive-health platform, with affiliated locations in Bangkok, Kuala Lumpur, Los Angeles, Singapore and Manila, backed by investors including Thiel Capital and LifeX Ventures (per GenPrime network disclosures).

The boutique-style clinic was designed around patient privacy and is equipped with a Class 100 ultra-clean workstation, micromanipulation systems and PCR instrumentation; its embryology laboratory program was developed in collaboration with Genea Fertility (Australia), and select GenPrime sites run Geri time-lapse embryo monitoring. The clinic does not publish age-specific clinical pregnancy rates, but its public laboratory data show about 90% of cases cultured to the blastocyst stage and almost 70% of patients leaving an IVF cycle with at least one embryo frozen — consistent indicators of lab performance (clinic website, treatment pages).

On Google Maps the clinic holds a 5.0 rating from 795 reviews with 584 booked appointments recorded in the ProIVF system (as of August 2026).

Accreditations & Awards

• Southeast Asia Best Assisted Reproductive Medical Institution 2024 — awarded at the Global Health Asia-Pacific (GHAPAC) Summit in Phuket, Thailand
• World Fertility Awards 2025 (New York): medical director Dr. Mathi Arasu Muthusamy was selected as a judge for the inaugural edition, an international recognition of the clinic’s clinical leadership
• KKLIU 3823/EXP 31.12.2027: Ministry of Health Malaysia medical advertising license; business registration 201801020326 (1282345-H)
• Note: the clinic’s care environment is described in third-party coverage as modeled on JCI standards, but no JCI certification is displayed on the official website or verifiable through the JCI portal; we list only the licenses confirmed above

Why Choose Ever-Link Fertility Centre

• Early Asia access to NICS non-invasive screening: one of the first clinics in Asia to offer NICS-A, a non-invasive PGT-A performed on culture medium without removing embryo cells (official genetic screening page)
• Full genetic testing suite: PGT-A for chromosome aneuploidy, PGT-M for single-gene disease such as thalassemia, PGT-SR for structural rearrangements, plus ERA endometrial receptivity analysis to time transfer
• Broad protocol library for difficult cases: antagonist, microdose flare and Mild IVF approaches tailored to low ovarian reserve, endometriosis, PCOS/OHSS history and older patients
• Strong laboratory track record: ~90% blastocyst culture rate and ~70% of patients with freeze-ready embryos per clinic-published data
• One-stop medical tourism: partnership with established medical tourism agencies covering pre-arrival planning through post-treatment follow-up, with Mandarin-speaking coordinators and pre-treatment checks that can be started in the home country
• International network effect: as part of GenPrime/Rhea Fertility, clinical protocols and lab standards are shared across clinics in five countries

IVF & Fertility Services

• In Vitro Fertilisation (IVF) and Intracytoplasmic Sperm Injection (ICSI)
• Intrauterine Insemination (IUI), with partner or donor sperm, fresh or frozen
• PGT-A / PGT-M / PGT-SR preimplantation genetic testing
• NICS — non-invasive PGT-A without embryo biopsy
• ERA — endometrial receptivity analysis for transfer timing
• Mild IVF (low-dose stimulation) for low reserve, PCOS, endometriosis, breast cancer patients
• Frozen Embryo Transfer (FET) with natural, hormone-replacement or stimulated endometrial preparation
• Fertility preservation: egg and embryo freezing (vitrification)
• Surgical Sperm Retrieval (SSR): PESA and TESA for azoospermia
• Repeated implantation failure (RIF) workup: chromosomal, uterine, maternal blood-factor evaluation

Fees & Packages

The official website does not publish treatment prices, referring only to “reasonable IVF treatment cost in Malaysia”. Actual package pricing — and the currency conversion to USD — depends on protocol, medication dosage and genetic-testing add-ons, so contact the clinic or an authorized medical tourism partner for a current written quote before booking. Third-party Chinese medical tourism partners advertise bundled journeys that split treatment between home-country stimulation and a short Malaysia stay for retrieval or transfer, but no verified price list is publicly available.

For budgeting context, Malaysia is generally one of the more affordable destinations for IVF in Asia, typically priced below Singapore, Japan and Western countries at comparable lab technology levels.

Patient Journey

Based on the clinic’s official IVF process page and international patient program:

1. Online consultation — submit an inquiry; a medical consultant replies within about 2 working days to review history and plan an initial assessment
2. Home-country pre-checks (optional) — baseline bloodwork and ultrasound can be completed locally and reviewed by the clinic before travel
3. Ovarian stimulation (9-10 days) — arrive around cycle day 2-3; daily subcutaneous FSH injections with alternate-day transvaginal ultrasound and hormone monitoring
4. Trigger and egg collection (OPU) — trigger shot matures the eggs; retrieval is performed 35-37 hours later in the on-site operating theatre under sedation/anaesthesia, taking roughly 10-15 minutes
5. Fertilisation and culture (5-7 days) — conventional IVF or ICSI; embryos cultured to day 3 or day 5-6 blastocyst, with PGT/NICS sampling when planned
6. Embryo transfer — 1-2 embryos placed through a fine catheter under abdominal ultrasound guidance, a 2-3 minute procedure without anaesthesia
7. Pregnancy test and follow-up — blood hCG 12-14 days after transfer; surplus embryos are vitrified for future FET cycles, and international patients can return home and be monitored remotely

Local Legal Framework

Malaysia has one of the more permissive and well-regulated ART environments in Asia for international patients:

• IVF, ICSI, IUI and FET are legal and regulated by the Ministry of Health; the clinic holds its KKLIU advertising license accordingly
• PGT (PGT-A/PGT-M/PGT-SR) is permitted for medical indications, including avoidance of hereditary disease such as thalassemia
• Egg and embryo freezing are legal and widely practiced for preservation
• Donor gametes: permitted under restrictions — donor egg programs are not available to Muslim patients, who are governed by Islamic law; donor sperm for IUI is offered subject to regulatory conditions
• Surrogacy: not legally recognized in Malaysia, and commercial surrogacy arrangements are unlawful
• Medical tourism: regulated through the Malaysia Healthcare Travel Council (MHTC), which licenses and monitors facilities serving international patients

Location

• Address: Unit G-2, Level Ground, The Podium Tower 3, UOA Business Park, No 1, Jalan Pengaturcara U1/51A, Seksyen U1, 40150 Shah Alam, Selangor Darul Ehsan, Malaysia
• Phone: +603 5888 8335
• Clinic hours: Monday-Friday 9:00-16:30; Saturday 9:00-12:30; Sunday and public holidays 9:00-11:00 for monitoring and procedures by appointment only (official contact page)

The clinic sits in UOA Business Park in Shah Alam’s Subang area, roughly 25-30 minutes from central Kuala Lumpur and about 15 minutes from Sultan Abdul Aziz Shah (Subang) Airport; ride-hailing services reach the tower directly, and the Podium offers visitor parking.